The Food and Drug Administration (FDA) US has stamped its seal of approval on Novartis’ heart failure medicine dubbed Entresto. Available to patients whose condition is classified NYHA class II-IV through prescription,…
Tag: Novartis
Novartis drug against psoriatic arthritis shows sustained efficacy
Novartis has revealed thee results of its pivotal Phase III FUTURE 2 study of secukinumab in psoriatic arthritis (PsA) with majority of patients showing sustained improvements over the course of one year…
Novartis gains EU approval for Zykadia
Novartis announced today that the European Commission has approved Zykadia (ceritinib) to treat adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. The approval…
Novartis inks deal with Google to develop ‘smart contact lenses’
Swiss Drug giant Novartis on Tuesday announced it has entered into a deal with Google for development of a smart lens designed to correct wearer’s vision and monitor blood sugar levels.